December 18, 2002
American Physiological Society
SR141716, a potent and selective central cannabinoid (CB1) receptor antagonist, has been shown to induce a significant decrease in food intake and body weight gain and reduce the intake of a high fat diet in these obese rats. Now, a new research effort seeks to assess the effect of SR141716 in a diet-induced obesity model.
December 17, 2002 (Bethesda, MD) -- That people are getting fatter is not news. Around the globe, physically demanding occupations like farming and mining are now carried out by machines. Western values such as television and automobiles are now encroaching on the most isolated environments. Finally, a highly processed diet -- along with a sedentary lifestyle -- is the likely culprit in the high rates of obesity seen among indigenous peoples who were originally hunters and foragers. Now they eat a diet that is "entirely store bought and provided by truck." Scientists and anthropologists have observed that in some societies, a high rate of infectious disease seems to be keeping children's weight low or substandard while many of the adults are obese. In effect, very small children evolve very quickly into obese adults.
The above story is based on materials provided by American Physiological Society. Note: Materials may be edited for content and length.
Cite This Page:
American Physiological Society. "Could An Anti-Marijuana Compound Hold The Key To Body Weight And Appetite Control?." ScienceDaily. ScienceDaily, 18 December 2002. <www.sciencedaily.com/releases/2002/12/021218074411.htm>.
American Physiological Society. (2002, December 18). Could An Anti-Marijuana Compound Hold The Key To Body Weight And Appetite Control?. ScienceDaily. Retrieved March 7, 2014 from www.sciencedaily.com/releases/2002/12/021218074411.htm
American Physiological Society. "Could An Anti-Marijuana Compound Hold The Key To Body Weight And Appetite Control?." ScienceDaily. www.sciencedaily.com/releases/2002/12/021218074411.htm (accessed March 7, 2014).